{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:46:33Z","timestamp":1785545193185,"version":"3.56.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.healun.2013.12.012","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T11:30:36Z","timestamp":1388748636000},"page":"341-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Biomarkers for the prognosis of pulmonary arterial hypertension: Holy grail or flying circus?"],"prefix":"10.1016","volume":"33","author":[{"given":"Fr\u00e9d\u00e9ric","family":"Lador","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola M.","family":"Soccal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Sitbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2013.12.012_bib1","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2013.12.012_bib2","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrcardio.2011.104","article-title":"Treatment of pulmonary arterial hypertension with targeted therapies","volume":"8","author":"O\u2032Callaghan","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.healun.2013.12.012_bib3","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/01.CIR.102.8.865","article-title":"Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension","volume":"102","author":"Nagaya","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2013.12.012_bib4","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1378\/chest.129.5.1313","article-title":"Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension","volume":"129","author":"Fijalkowska","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.healun.2013.12.012_bib5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.amjcard.2006.02.061","article-title":"N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension","volume":"98","author":"Andreassen","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2013.12.012_bib6","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2013.12.012_bib7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0003-4975(02)03654-8","article-title":"Plasma brain natriuretic peptide as a noninvasive marker for efficacy of pulmonary thromboendarterectomy","volume":"74","author":"Nagaya","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2013.12.012_bib8","doi-asserted-by":"crossref","first-page":"e14506","DOI":"10.1371\/journal.pone.0014506","article-title":"Identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1","volume":"6","author":"Jankowska","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.healun.2013.12.012_bib9","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/ajh.2010.149","article-title":"Plasma C-terminal pro-endothelin-1 is associated with target-organ damage in African Americans with hypertension","volume":"23","author":"Habib","year":"2010","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.healun.2013.12.012_bib10","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.healun.2013.06.020","article-title":"An exploratory panel of biomarkers for risk prediction in pulmonary hypertension: emerging role of CT-proET-1","volume":"32","author":"Silva Marques","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2013.12.012_bib11","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/0735-1097(88)90282-3","article-title":"Verapamil impairs secretion of stimulated atrial natriuretic factor in humans","volume":"11","author":"Haufe","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2013.12.012_bib12","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","volume":"111","author":"Sitbon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2013.12.012_bib13","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1055\/s-0033-1356549","article-title":"A practical approach of pulmonary hypertension in the elderly","volume":"34","author":"Lador","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.healun.2013.12.012_bib14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic","volume":"289","author":"Redfield","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2013.12.012_bib15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","article-title":"Primary pulmonary hypertension. A national prospective study","volume":"107","author":"Rich","year":"1987","journal-title":"Ann Intern Med"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249813015660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249813015660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:27:41Z","timestamp":1762331261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249813015660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1053249813015660"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2013.12.012","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers for the prognosis of pulmonary arterial hypertension: Holy grail or flying circus?","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2013.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}